Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07BDY
|
||||
| Former ID |
DIB015383
|
||||
| Drug Name |
Tisocalcitate
|
||||
| Synonyms |
SH-597; ZK-156942; Calcitriol analog (topical formulation), Schering AG
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Psoriasis [ICD9: 696; ICD10:L40] | Discontinued in Phase 2 | [547723] | ||
| Company |
Bayer Schering Pharma AG
|
||||
| Formula |
C31H48O5
|
||||
| Canonical SMILES |
[C@@]12([C@H](/C(=C/C=C/3\C(=C)[C@H](C[C@@H](C3)O)O)/CC<br />C2)CC[C@@H]1[C@@H](/C=C/[C@H](C(C(=O)OC(C)C)(C)C)O)C)C
|
||||
| CAS Number |
CAS 156965-06-9
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Vitamin D receptor | Target Info | Inhibitor | [544140] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| PANTHER Pathway | Vitamin D metabolism and pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.